Personalized peptide vaccines : A new therapeutic modality for cancer

スポンサーリンク

概要

• 論文の詳細を見る
• 2006-10-10

著者

• ITOH Kyogo

  Departments of Immunology, Kurume University School of Medicine

• YAMADA Akira

  Cancer Vaccine Development Division, Kurume University Research Center for Innovative Cancer Therapy

• Itoh Kyogo

  Department Of Immunology Kurume University School Of Medicine Center Of The 21st Century Coe Program

• Itoh Kyogo

  Department Of Immunology

• Yamada Akira

  Cancer Vaccine Development Division Kurume University Research Center For Innovative Cancer Therapy

関連論文

• Analysis of tumor necrosis factor-α production and polymorphisms of the tumor necrosis factor-α gene in individuals with a history of Kawasaki disease
• Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b^+ HLA-A24^+ patients
• New Epitope Peptides Derived from Hepatitis C Virus (HCV) 2a Which Have the Capacity to Induce Cytotoxic T Lymphocytes in HLA-A2^+ HCV-Infected Patients
• Phase I trial of patient-oriented vaccination in HLA-A2-positive patients with metastatic hormone-refractory prostate cancer
• Sequence Analysis of Genes Encoding Rodent Homologues of the Human Tumor-rejection Antigen SART-1
• Immunological evaluation of personalized peptide vaccination monotherapy in patients with castration-resistant prostate cancer
• Cytotoxicity Induced by Erythrina variegata Serine Proteinase Inhibitors in Tumor Hematopoietic Stem Cell Lines
• Personalized peptide vaccines : A new therapeutic modality for cancer
• Expression of Tumor-rejection Antigens in Gynecologic Cancers
• Expression of the SART-1 Antigens in Uterine Cancers
• Target molecules in specific immunotherapy against prostate cancer
• Identification of a prostate-specific membrane antigen-derived peptide capable of eliciting both cellular and humoral immune responses in HLA-A24^+ prostate cancer patients
• Expression of MAGE-1 Gene by Esophageal Carcinomas
• Histocompatibility Leukocyte Antigen-A2402-restricted Cytotoxic T Lymphocytes Recognizing Adenocarcinoma in Tumor-infiltrating Lymphocytes of Patients with Colon Cancer
• Expression of SART3 Tumor-rejection Antigen in Gastric Cancers
• Changes in the Mononuclear Cell Subpopulations of Rat Cardiac Transplant Recipients Administered FK506 for the Treatment of Ongoing Rejection
• Phase I trial of personalized peptide vaccination for cytokine-refractory metastatic renal cell carcinoma patients
• Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy
• Antibody Reactive to a Hepatitis C Virus (HCV)-Derived Peptide Capable of Inducing HLA-A2 Restricted Cytotoxic T Lymphocytes Is Detectable in a Majority of HCV-Infected Individuals without HLA-A2 Restriction
• Chemohormonal therapy as primary treatment for metastatic prostate cancer : A randomized study of estramustine phosphate plus luteinizing hormone-releasing hormone agonist versus flutamide plus luteinizing hormone-releasing hormone agonist
• Immunological evaluation of peptide vaccination for patients with gastric cancer based on pre-existing cellular response to peptide
• Immunological evaluation of CTL precursor-oriented vaccines for advanced lung cancer patients
• Serine Proteinase Inhibitor 9 Can Be Recognized by Cytotoxic T Lymphocytes of Epithelial Cancer Patients
• Identification of Cyclophilin B-derived Peptides Capable of Inducing Histocompatibility Leukocyte Antigen-A2-restricted and Tumor-specific Cytotoxic T Lymphocytes
• Mouse Homologue of the Human SART3 Gene Encoding Tumor-rejection Antigen
• Detection of Circulating Tumor Cells in Patients with Prostate Cancer Using Prostate Specific Membrane-Derived Primers in the Polymerase Chain Reaction
• Spectroscopic Analysis of the Cytoagglutinating Activity of Abrin-b Isolated from Abrus precatorius Seeds against Leukemic Cells
• A GENE ENCODING SQUAMOUS CELL CARCINOMA ANTIGENS RECOGNIZED BY CYTOTOXIC T LYMPHOCYTE
• Genes Encoding Antigenic Peptides of Human Epithelial Cancers Recognized by Cytotoxic T Lymphocytes
• Detection of MAGE-4 Protein in Sera of Lung Cancer Patients
• Human Tumor Rejection Antigens MAGE1^1
• Cytokine Production by T Cells Infiltrating in the Eye of Uveitis Patients
• Induction of MAGE Genes in Lymphoid Cells by the Demethylating Agent 5-Aza-2'-deoxycytidine
• In Vitro Effects of Immunosuppressive Agents on Cytokine Production by HTLV-I-Infected T Cell Clones Derived from the Ocular Fluid of Patients with HTLV-I Uveitis
• Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanona antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease
• High prevalence of hepatitis C virus antibody and RNA in patients with head and neck squamous cell carcinoma
• Noninvasive Estimation of Aortic Blood Flow Velocty by Bioelectrical Impedance
• Erythropoietin-producing hepatocyte B6 variant-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2^+ glioma patients
• Elevation of Serum MAGE-4 Protein Levels and Prediction of Hepatocellular Carcinogenesis in Patients with Liver Cirrhosis
• Detection of MAGE-4 Protein in the Sera of Patients with Hepatitis-C Virus-associated Hepatocellular Carcinoma and Liver Cirrhosis
• Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles
• Identification of peptides applicable as vaccines for HLA-A26-positive cancer patients
• -0137-ACUTE AND CHRONIC EFFECTS OF CIGARETTE SMOKING ON CARDIAC AUTONOMIC FUNCTION ASSESSED BY HEART RATE SPECTRAL ANALYSIS
• Effectiveness of glycyrrhizin for oral lichen planus in patients with chronic HCV infection
• Evaluation of a new oil adjuvant for use in peptide-based cancer vaccination
• Exploring immune therapy for renal cancer
• Development of a New Diagnostic Tool for Pancreatic Cancer: Simultaneous Measurement of Antibodies against Peptides Recognized by Cytotoxic T Lymphocytes
• Increase in the Capability of Interleukin 2 Gene-Transduced Renal Cell Carcinoma Cells to Induce Cytotoxic Lymphocytes.
• Haptoglobin Proved a Prognostic Biomarker in Peripheral Blood of Patients with Personalized Peptide Vaccinations for Advanced Castration-Resistant Prostate Cancer

もっと見る 閉じる

スポンサーリンク